AMERICAN SHARED HOSPITAL SERVICES
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $AMS in the last 7 days.
No SEC Form 4 filings for $AMS in the last 30 days.
See all $AMS insider activity →South Africa demands Zimbabwe repay $228M owed to platinum miners. Minister Mantashe seeks repayment of 30% deducted from PGM producers. Zimbabwe's policy retains export proceeds, causing cash-flow strains. Valterra Platinum and Impala Platinum report significant outstanding balances. Zimbabwe is the world's third-largest PGM producer.
American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.
American Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.
Recent AMS coverage spans earnings, regulation and corporate actions.
Potential cash‑flow strain if payments are delayed further.
Loss widening alongside revenue growth suggests margin pressure from operating cost growth, partially offset by improved liquidity from financing.
Near-term sentiment likely mixed: strong volume and revenue growth, offset by credit-loss and legal costs tied to the credit agreement amendment.
Going-concern language tied to covenant noncompliance and suspended revolver availability increases near-term credit and refinancing risk despite higher volumes.
Earnings show modest revenue growth but continued losses, which can pressure valuation and influence near-term positioning.
alphai scores every news story that mentions AMS with an AI model for sentiment and relevance, and aggregates insider trades from AMERICAN SHARED HOSPITAL SERVICES's SEC EDGAR Form 4 filings. Figures refresh continuously.
South Africa demands Zimbabwe repay $228M owed to platinum miners. Minister Mantashe seeks repayment of 30% deducted from PGM producers. Zimbabwe's policy retains export proceeds, causing cash-flow strains. Valterra Platinum and Impala Platinum report significant outstanding balances. Zimbabwe is the world's third-largest PGM producer.
2 min readAmerican Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.
4 min readAmerican Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.
6 min readAmerican Shared Hospital Services (NYSE: AMS) reported Q2 2026 revenue of $8.43M and $15.51M for the first half, up from $7.07M and $13.18M a year earlier, driven by direct patient services and higher PBRT and Gamma Knife volumes. The company posted net losses of $0.51M in Q2 and $1.13M for six months and disclosed substantial doubt about its going concern due to covenant breaches and debt default notices.
6 min readAmerican Shared Hospital Services reported Q2 2026 sales of $8.43 million versus $7.07 million a year earlier. Net loss was $0.514 million versus $0.28 million. Basic and diluted loss per share were $0.07 versus $0.04. For six months, sales rose to $15.51 million from $13.18 million, with net loss of $1.13 million versus $0.905 million.
1 min readAmerican Shared Hospital Services (AMS) reported Q2 2026 revenue up 19% year over year to $8.4M, citing growth in Direct Patient Services and international markets. The company said cash generation was strong, but noted a $909K credit loss and refinancing needs as key risks. It attributed the outlook to strategic investments and operational improvements.
1 min readAmerican Shared Hospital Services reported Q2 2026 revenue of $8.4 million, up 19.2% year over year and above the $7.56 million forecast. Adjusted EPS was a loss of $0.07 versus an expected loss of $0.02. Direct patient services rose to $4.9 million and proton beam revenue to about $2.3 million. Cash and equivalents were $6.8 million; management discussed refinancing debt due in 2027.
6 min readAmerican Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.
6 min readAMERICAN SHARED HOSPITAL SERVICES (AMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results Second Quarter Revenue Increased 19% to $8.4 Million Driven by Strong Growth from Direct Patient Services Operating Cash Flow Reached $4.4 Million in First Half of 2026 Con
6 min readams OSRAM reported Q2/26 revenues of EUR 805m, at the high end of guidance, with 16.9% adjusted EBITDA margin (EUR 136m) and 14.2% non-adjusted EBITDA margin (EUR 115m). It placed EUR 1bn senior notes at 7.25%. Q3/26 revenue guidance is EUR 770m to 870m and adjusted EBITDA margin 16.0% +/-1.5%.
7 min read
